Table 1 Baseline Characteristics.

From: Impact of Anemia and Dual Antiplatelet Therapy on Mortality in Patients Undergoing Percutaneous Coronary Intervention with Drug-Eluting Stents

Baseline Characteristics

No Anemia

Mild Anemia

Moderate-severe Anemia

P Value

Total, n

3163(77.0)

866(21.1)

80(1.9)

 

Clinical features

 Age, y, (SD)

63.34 ± 8.81

66.93 ± 10.07

69.87 ± 11.24

<0.001

 Male gender, n (%)

2305(72.9)

547(63.2)

28(35.0)

<0.001

 Hypertension, n (%)

1893(59.8)

536(61.9)

58(72.5)

0.049

 Diabetes mellitus, n (%)

722(22.8)

259(29.9)

25(31.3)

<0.001

 Current smoker, n (%)

1591(50.3)

333(38.5)

16(20.0)

<0.001

 Hyperlipidemia, n (%)

484(15.3)

100(11.5)

10(12.5)

0.016

 Previous heart failure, n (%)

203(6.4)

61(7.0)

4(5.0)

0.669

 Hb, mg/L,

143.41 ± 12.74

117.86 ± 7.83

88.28 ± 12.28

<0.001

 eGFR, <90 ml/min/1.72 m2, n (%)

72(2.3)

62(7.2)

20(25.0)

<0.001

 LVEF, <50%, n (%)

196(6.2)

81(9.4)

12(15.0)

<0.001

Clinical syndromes

   

<0.001

 ACS

2274(71.9)

767(88.6)

67(83.8)

 

 Non-ACS

889(28.1)

99(11.4)

13(16.2)

 
  1. SD indicates standard deviation; eGFR, estimated glomerular filtration rate; LVEF, left ventricular ejection fraction; ACS, acute coronary syndrome.